Sjogren’s Syndrome

  • Nages Nagaratnam
  • Kujan Nagaratnam
  • Gary Cheuk
Reference work entry


The syndrome may present alone (primary) or in association with an underlying connective tissue disorder (secondary). In elderly people Sjogren’s syndrome (SS) is subclinical, relatively common and benign. In the elderly Sjogren’s syndrome should be considered when sicca symptoms occur with systemic manifestations. Approximately 40% of xerostomia in the elderly is due to Sjorgren’s syndrome and accounts up to 20% of Sjorgren’s syndrome; arthralgias, Raynaud’s phenomenon and purpura were common extraglandular manifestations. It is important to distinguish age-related gland pathology, drug-induced ocular and oral dryness from that due to SS.


Sjogren’s syndrome Xerostomia Raynaud’s phenomenon Purpura 


  1. 1.
    Miller AV. Sjogren Syndrome Clinical Presentation. Medscape. accessed on 11 September 2015.
  2. 2.
    Garcia-Carrasco M, Ramos-Casais M, Rosas J, Pallaras L, Calvo-Alen J, Cervera R, et al. Primary Sjogren’s syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270–280.CrossRefPubMedGoogle Scholar
  3. 3.
    Gentric-Tilly A.Sjogren’s syndrome in the elderly. Ann Med Interne (Paris). 2002;153(6):378–82.PubMedGoogle Scholar
  4. 4.
    Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjogren’s syndrome. Nat Clin Pract Rheumatol. 2006;2(5):252–61.CrossRefPubMedGoogle Scholar
  5. 5.
    Hashimi AC. Xerostomia secondary to Sjorgren’s syndrome in the elderly: recognition and management. Drugs Aging. 2005;22(11):887–889.CrossRefGoogle Scholar
  6. 6.
    Botsios C, Furlan A, Oatuni P, Sfriso P, Andretta M, Ometto F, et al. Elderly onset of primary Sjogren’s syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine. 2011;78(2):171–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Drosos AA, Andonpoulos AP, Costopoulos JS, Papadimitrio CS, Moutsopoulos HM. Prevalence of primary Sjogren’s syndrome in an elderly population. Rheumatology. 1988;27(27):123–127.CrossRefGoogle Scholar
  8. 8.
    Garcia-Carrasco M, Fuentes-Alexandro S, Escarcega RO, Salgado G, Riebeling C, Cervera R. Pathophysiology of Sjogren’s syndrome. Arch Med Res. 2006;37(8);921–32.CrossRefPubMedGoogle Scholar
  9. 9.
    Moerman RV, Bootsma H, Kroese FG, Vissink A. Sjogren’s syndrome in older patients: aetiology, diagnosis and management. Drugs Aging. 2013;30(3):137–53.CrossRefPubMedGoogle Scholar
  10. 10.
    Kruszka P, O’Brian RJ. Diagnosis and management of Sjogren’s syndrome. Am Fam Physician. 2009;79(6):465–470.PubMedGoogle Scholar
  11. 11.
    Vitali C, Bombadieri S, Jonsson S, Moutsopoulos HM, Alexander EL, Carsons SS, et al. for the European Study Group on Classification Criteria for Sjogren’s syndrome. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–558.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Yung RL, Francis S. Sjogren’s syndrome in the elderly. Chapter Geriatric Rheumatology.pp 287–291. accessed 11 September, 2015.
  13. 13.
    Tsifetaki N, Kitsos G, Paschides CA, Alamanos Y, Eftaxias V, Voulgari PV, et al. Oral pilocarpine for the treatment of ocular symptoms in patients with Sjogren’s syndrome: a randomized 12 week controlled study. Ann Rheum Dis. 2003;62(12):1204–1207.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Ono M, Takamura E, Shinozaki K, Tsumura T, Hamano T, Yagi Y, et al. Therapeutic effect of cevimeline on dry eye in patients with Sjogren’s syndrome: a randomized, double-blind clinical study. Am J Ophthamol. 2004;138(1):6–17.CrossRefGoogle Scholar
  15. 15.
    Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren’s syndrome. Arch Intern Med. 2004;164(12):1275–1284.CrossRefPubMedGoogle Scholar
  16. 16.
    Ramos-Cassais M, Tzioufas AG, Font J. Primary sjogren’s syndrome: new clinical and therapeutic concepts. Ann Rheum Dis. 2005;64(3):347–354.CrossRefGoogle Scholar
  17. 17.
    Fox RI, Stern M. Sjogren’s syndrome: mechanisms of pathogenesis involve interaction of immune and neurosensory systems. Scand J Rheumatol Suppl. 2002;116:3–13.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nages Nagaratnam
    • 1
  • Kujan Nagaratnam
    • 1
  • Gary Cheuk
    • 2
  1. 1.The University of SydneyWestmead Clinical SchoolWestmeadAustralia
  2. 2.Rehabilitation and Aged Care ServiceBlacktown-Mt Druitt HospitalMount DruittAustralia

Personalised recommendations